Search Within

Prasad S Adusumilli

  1. "GSK Faculty"
Formats
  1. Journal Article (39)
  2. Meeting Abstract (38)
Groups
  1. GSK Faculty (77)
  2. Surgery (77)
  3. Department of Medicine (74)
  4. Department of Pathology and Laboratory Medicine (46)
  5. Solid Tumor Oncology Division (45)
  6. Hematologic Malignancies, Division of (42)

More Groups

People
  1. William Travis (35)
  2. Valerie Rusch (34)
  3. Michel Sadelain (33)
  4. Marjorie Zauderer (29)
  5. Marc Ladanyi (26)
  6. David Jones (21)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (2)
  4. 2022 (5)
  5. 2021 (14)
  6. 2020 (4)

More Years

Publications
  1. Journal of Thoracic Oncology (17)
  2. Modern Pathology (10)
  3. Journal of Clinical Oncology (7)
  4. Clinical Cancer Research (6)
  5. Laboratory Investigation (5)
  6. Cancer Research (3)

More Publications

Publishers
  1. Elsevier Inc. (18)
  2. American Association for Cancer Research (11)
  3. Nature Publishing Group (11)
  4. Nature Research (10)
  5. American Society of Clinical Oncology (7)
  6. Springer (4)

More Publishers

Results (77)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mesothelin-targeted T Cells Gene-Engineered with 4-1BB Costimulation Overcome Tumor-Mediated Immunoinhibition and Eradicate Established Solid Tumors
    Meeting Abstract

    Cherkassky, L.; Villena-Vargas, J.; Morello, A.; Rusch, V. W.; Sadelain, M.; Adusumilli, P.
    Journal of the American College of Surgeons (2014)

    Fulltext@MSK | Save
  • Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma
    Journal Article

    Kachala, S. S.; Bograd, A. J.; Villena-Vargas, J.; Suzuki, K.; Servais, E. L.; Kadota, K.; Chou, J.; Sima, C. S.; Vertes, E.; Rusch, V. W.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • T-cell imaging to noninvasively monitor adoptive T-cell therapy for thoracic malignancies
    Meeting Abstract

    Villena-Vargas, J.; Rodriguez, L. A.; Moroz, M.; Cherkassky, L.; Rusch, V. W.; Sadelain, M.; Ponomarev, V.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Critical role of CD28 costimulation in tumor-targeted T-cell therapy clinical trial for pleural malignancies
    Meeting Abstract

    Villena-Vargas, J.; Cherkassky, L.; Colovos, C.; Servais, E.; Rodriguez, L. A.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • CD8 T-cell infiltration and tumor IL-7R expression are independent prognostic factors in epithelioid malignant pleural mesothelioma
    Meeting Abstract

    Ujiie, H.; Buitrago, D.; Nitadori, J.; Kadota, K.; Krug, L. M.; Travis, W. D.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer: Implications for immunotherapy
    Meeting Abstract

    Lee, M. C.; Kadota, K.; Ujiie, H.; Rizk, N. P.; Travis, W. D.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Prognostic impact of tumor-infiltrating immune cells in lung squamous cell carcinoma
    Meeting Abstract

    Bograd, A.; Kadota, K.; Nitadori, J.; Cherkassky, L.; Rusch, V. W.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence
    Journal Article

    Suzuki, K.; Kadota, K.; Sima, C. S.; Nitadori, J.; Rusch, V. W.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients
    Journal Article

    Servais, E. L.; Colovos, C.; Rodriguez, L.; Bograd, A. J.; Nitadori, J. I.; Sima, C.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save